We will use your email address only for sending you newsletters. Please see our Privacy Notice for details of your
Read moreHome »
Can a combination immune therapy reduce genital herpes outbreaks?
Yale investigators have shown that the combination of a vaccine and a medicated cream is a promising strategy to dramatically
Read moreCombination therapy treats leishmaniasis, HIV patients
Coinfection with visceral leishmaniasis (VL) and human immunodeficiency virus (HIV) has been observed in at least 35 countries on four
Read moreHuman activity may influence the distribution and transmission of Bartonella bacteria
Bartonella bacteria are disease-causing, blood-borne pathogens found in various mammal species. A study in PLOS Neglected Tropical Diseases by Hannah
Read moreLong-term study shows that HIV-2 is deadlier than previously thought
A study published in The Lancet HIV shows that HIV-2 is more pathogenic than previously demonstrated. The new findings indicate
Read moreIn clinical trials, new antibody therapy controls HIV for months after treatment
Thanks to improvements in antiretroviral therapy, HIV is now a manageable condition. Yet even the best drugs do not entirely
Read moreProof-of-concept HIV immunotherapy study passes Phase 1 safety trial
Preliminary results from a phase I clinical trial have demonstrated the safety and tolerability of a cell therapy involving the
Read moreTibetan sheep highly susceptible to human plague, originates from marmots
In the Qinghai-Tibet plateau, one of the region’s highest risk areas for human plague, Himalayan marmots are the primary carriers
Read moreThe medicine of the future against infection and inflammation?
Researchers at Lund University in Sweden, have in collaboration with colleagues in Copenhagen and Singapore, mapped how the body’s own
Read moreCrowdsourcing friendly bacteria helps superbug cause infection
Antimicrobial resistant pathogens crowdsource friendly bacteria to survive in immune cells and cause disease, a new study by the University
Read more